218 related articles for article (PubMed ID: 8935799)
1. Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213.
Deveney AM; Waddington JL
Psychopharmacology (Berl); 1996 Mar; 124(1-2):40-9. PubMed ID: 8935799
[TBL] [Abstract][Full Text] [Related]
2. The effects of clozapine on behavioural responses to the selective 'D1-like' dopamine receptor agonist, A 68930, and to the selective 'D2-like' agonist, RU 24213.
Daly SA; Waddington JL
Br J Pharmacol; 1994 Nov; 113(3):839-44. PubMed ID: 7858875
[TBL] [Abstract][Full Text] [Related]
3. Evidence for dopamine 'D1-like' receptor subtypes in the behavioural effects of two new selective antagonists, LY 270411 and BW 737C.
Deveney AM; Waddington JL
Eur J Pharmacol; 1996 Dec; 317(2-3):175-81. PubMed ID: 8997598
[TBL] [Abstract][Full Text] [Related]
4. Anti-cataleptic effects of clozapine, but not olanzapine and quetiapine, on SCH 23390- or raclopride-induced catalepsy in rats.
Ahlqvist J; Isacson R; Wahlestedt C; Salmi P
Eur Neuropsychopharmacol; 2003 May; 13(3):177-82. PubMed ID: 12729943
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment.
Tarazi FI; Zhang K; Baldessarini RJ
J Pharmacol Exp Ther; 2001 May; 297(2):711-7. PubMed ID: 11303062
[TBL] [Abstract][Full Text] [Related]
6. Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat.
Oerther S; Ahlenius S
J Pharmacol Exp Ther; 2000 Feb; 292(2):731-6. PubMed ID: 10640312
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of olanzapine at dopamine D1 and D2 receptors in dopamine depleted animals.
Ninan I; Kulkarni SK
Psychopharmacology (Berl); 1999 Feb; 142(2):175-81. PubMed ID: 10102770
[TBL] [Abstract][Full Text] [Related]
8. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
Deveney AM; Waddington JL
Br J Pharmacol; 1995 Oct; 116(3):2120-6. PubMed ID: 8640354
[TBL] [Abstract][Full Text] [Related]
10. The interaction of clozapine with dopamine D1 versus dopamine D2 receptor-mediated function: behavioural indices.
Murray AM; Waddington JL
Eur J Pharmacol; 1990 Sep; 186(1):79-86. PubMed ID: 2149339
[TBL] [Abstract][Full Text] [Related]
11. Two directions of dopamine D1/D2 receptor interaction in studies of behavioural regulation: a finding generic to four new, selective dopamine D1 receptor antagonists.
Daly SA; Waddington JL
Eur J Pharmacol; 1992 Mar; 213(2):251-8. PubMed ID: 1387846
[TBL] [Abstract][Full Text] [Related]
12. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex.
Gessa GL; Devoto P; Diana M; Flore G; Melis M; Pistis M
Neuropsychopharmacology; 2000 Jun; 22(6):642-9. PubMed ID: 10788763
[TBL] [Abstract][Full Text] [Related]
13. Antagonism by pimozide of olanzapine-induced hypothermia.
Ninan I; Kulkarni SK
Fundam Clin Pharmacol; 1999; 13(5):541-6. PubMed ID: 10520726
[TBL] [Abstract][Full Text] [Related]
14. Psychopharmacological distinction between novel full-efficacy "D1-like" dopamine receptor agonists.
Deveney AM; Waddington JL
Pharmacol Biochem Behav; 1997 Oct; 58(2):551-8. PubMed ID: 9300618
[TBL] [Abstract][Full Text] [Related]
15. The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors.
Zhang W; Bymaster FP
Psychopharmacology (Berl); 1999 Jan; 141(3):267-78. PubMed ID: 10027508
[TBL] [Abstract][Full Text] [Related]
16. Extended treatment with typical and atypical antipsychotic drugs differential effects on the densities of dopamine D2-like and GABAA receptors in rat striatum.
Dean B; Hussain T; Scarr E; Pavey G; Copolov DL
Life Sci; 2001 Aug; 69(11):1257-68. PubMed ID: 11521750
[TBL] [Abstract][Full Text] [Related]
17. Behavioural evidence for "D-1-like" dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C.
Daly SA; Waddington JL
Psychopharmacology (Berl); 1993; 113(1):45-50. PubMed ID: 7862827
[TBL] [Abstract][Full Text] [Related]
18. alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.
Kalkman HO; Loetscher E
Eur J Pharmacol; 2003 Feb; 462(1-3):33-40. PubMed ID: 12591093
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient.
Kapur S; Remington G
Biol Psychiatry; 2001 Dec; 50(11):873-83. PubMed ID: 11743942
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of olanzapine substitution in rats discriminating clozapine by the D2/3 agonist quinpirole.
Cole JC; Field M; Sumnall HR; Goudie AJ
Behav Pharmacol; 2007 May; 18(3):185-90. PubMed ID: 17426482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
